We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sucampo Investor Seeks Docs For Proposed Mallinckrodt Deal

Law360 (February 12, 2018, 8:54 PM EST) -- A shareholder hit Sucampo Pharmaceuticals Inc. with a books and records request suit Monday in Delaware’s Chancery Court over Mallinckrodt PLC’s proposed $1.2 billion buyout, alleging Mallinckrodt may have acquired an ownership interest in Sucampo through a side deal that could trigger a three-year moratorium on the merger.

Investor Andre Brown says the Irish drugmaker Mallinckrodt acquired the ownership interest of Sucampo’s founders ― about 32 percent of Sucampo’s outstanding equity ― through a side deal on Dec. 20, several days before Mallinckrodt announced its $1.2...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.